Panelists discuss how payer controls and prior authorization policies delay and derail LDL-lowering therapy.Panelists discuss how payer utilization management and prior authorization processes delay therapy initiation and contribute to high abandonment rates.The paperwork burden discourages prescribers and frustrates patients, often interrupting continuity of care. Panelists highlight that these barriers disproportionately affect lower-income populations and smaller […]
